BRCA1 and BRCA2 genes play a crucial role in repairing damaged DNA. Mutations in BRCA1 and BRCA2 substantially increase the likelihood of breast and ovarian cancer, respectively. This new research ...

Cancer therapy has advanced with molecularly targeted approaches and immunotherapy, yet chemotherapy remains essential for ...

Allarity Therapeutics, Inc. ("Allarity” or the "Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical company ...

(NASDAQ: IMNN), a clinical-stage company in late-stage development with its DNA-mediated immunotherapy, today reported financial results for the year ended December 31, 2024 and highlighted recent ...

Allarity Therapeutics, Inc. (“Allarity” or the “Company”) (NASDAQ: ALLR), a Phase 2 clinical-stage pharmaceutical ...

This comprehensive review revealed compelling evidence for stenoparib’s durable clinical benefit in platinum-resistant, advanced ovarian cancer patients ... resistant human cancer cell lines, ...

As a cancer treatment, PARP inhibitors stop the PARP from doing its repair work in cancer cells and the cell dies. There are different types of PARP inhibitor used to treat ovarian cancer ... You may ...

(People with this cancer are about 75% as likely as people who don't have it to live for at least 5 years after their diagnosis.) Ovarian germ cell tumors: 94% Ovarian stromal tumors: 86% The ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window 6.9% of ...

The peritoneum is a layer of thin tissue that lines the inside of the tummy (abdomen ... ovarian cancer at the same time as a separate womb (endometrial) cancer. Clear cell ovarian cancer can also be ...